{"id":341096,"date":"2026-11-05T22:22:28","date_gmt":"2026-11-05T16:52:28","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/fredun-pharmaceuticals-q2-results-fy27-pat-19-crore\/"},"modified":"2026-11-05T22:22:28","modified_gmt":"2026-11-05T16:52:28","slug":"fredun-pharmaceuticals-q2-results-fy27-pat-19-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/fredun-pharmaceuticals-q2-results-fy27-pat-19-crore\/","title":{"rendered":"Fredun Pharmaceuticals Q2 Results FY27: Net Profit Jumps 96.92% to Rs 18.57 Cr, Revenue Rs 267.64 Cr, PAT Rs 18.57 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Fredun Pharmaceuticals Q2 Results FY27 were declared on 5 November 2026 and cover the quarterly results for July to September 2026. Revenue stood at Rs 267.64 Cr, up 84.21% YoY from Rs 145.29 Cr, while net profit reached Rs 18.57 Cr against Rs 9.43 Cr, a 96.92% rise. This YoY growth in both lines is the central fact of the quarter.<\/p>\n<\/div>\n

Fredun Pharmaceuticals Ltd<\/a> (FREDUN) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 267.64 Cr and PAT of Rs 18.57 Cr. The results date was 5 November 2026, and Fredun Pharmaceuticals Q2 Results FY27 compare that quarter with July to September of last year, so every figure below reads as a YoY comparison.<\/p>\n

This results analysis of Fredun Pharmaceuticals Q2 Results covers the financial highlights, business drivers, outlook and risks that follow, as Univest reads the numbers. It starts with the Financial Highlights table, which sets revenue and net profit side by side for the two quarters.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n